DJ US Healthcare Ishares (IYH) 159.39 $IYH Relative Risk

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
DJ US Healthcare Ishares (IYH) 159.39 $IYH

Relative Risk Adjusted Return For Retirees And Those Who Prefer A Smoother Ride
Richard Shaw - at Seeking Alpha - Sat Mar 21, 12:17AM CDT

SPYG: 101.17 (+0.50), IYH: 159.39 (+0.86), VDC: 126.95 (+1.49), XLY: 76.77 (+0.59), IYC: 147.34 (+1.37), IBB: 366.52 (+1.27), XLV: 74.90 (+0.33), IVW: 117.19 (+0.95), VUG: 110.43 (+0.93), FVD: 24.42 (+0.25), XLP: 48.94 (+0.31), VCR: 124.36 (+1.22), JKE: 121.98 (+1.00), JKG: 155.25 (+1.49), IWF: 101.20 (+0.78), IXJ: 110.64 (+1.24), VHT: 139.38 (+0.70)

What To Expect When The Fed Actually Does Raise Rates
Dirk Leach - at Seeking Alpha - Thu Mar 19, 4:28PM CDT

RYH: 159.00 (+0.69), KXI: 92.72 (+1.23), IYH: 159.39 (+0.86), VDC: 126.95 (+1.49), IPS: 41.06 (+0.45), RXL: 149.91 (+1.63), XLV: 74.90 (+0.33), XLP: 48.94 (+0.31), SPY: 210.41 (+0.91), FSTA: 29.55 (+0.05), QQQ: 108.53 (+0.45), DIA: 180.96 (+1.30), FHLC: 36.29 (-0.04), RXD: 12.24 (-0.14), RHS: 107.06 (+0.54), IWM: 125.99 (+1.10), FXG: 45.17 (+0.30), CURE: 161.18 (+3.49), VHT: 139.38 (+0.70), FXH: 68.50 (+0.07)

Developing An Eye For R&D
The Financialist - Seeking Alpha - Tue Mar 17, 5:24AM CDT
Despite the strong economic recovery in the U.S., nominal global GDP growth over the next few years is unlikely to reach the levels reached just prior to the global financial crisis. Developed economies grew an average of 5 percent between 1997 and...
IYJ: 109.99 (+0.71), IYH: 159.39 (+0.86), IXJ: 110.64 (+1.24), IYW: 107.91 (+0.62)

12 Best Biotech and Health Care ETFs to Add to Your Portfolio
at The Street - Thu Mar 12, 9:49AM CDT
Biotech and health care are two of the hottest sectors in which to invest. TheStreet compiled a list of the best-rated ETFs tracking the two sectors.
IHE: 178.85 (-0.32), IHF: 134.41 (+0.34), XHE: 95.03 (-0.32), IYH: 159.39 (+0.86), XHS: 125.51 (+0.62), GRX: 11.23 (+0.07), FHLC: 36.29 (-0.04), IHI: 120.98 (+0.18), IXJ: 110.64 (+1.24), VHT: 139.38 (+0.70), FXH: 68.50 (+0.07), XLV: 74.90 (+0.33)

Healthcare Funds: Hale And Hearty
Morningstar - Seeking Alpha - Wed Mar 11, 11:39AM CDT
By Robert Goldsborough The healthcare sector's returns have continued to be very potent. More than almost any other corner of the U.S. equity market, healthcare stocks have dazzled in recent years, including the nearly five years since President...
IYH: 159.39 (+0.86), FHLC: 36.29 (-0.04), VHT: 139.38 (+0.70), XLV: 74.90 (+0.33)

Investors Find A Reason To Sell, Teeing Up A New Buying Opportunity
Scott Martindale - at Seeking Alpha - Mon Mar 09, 2:16PM CDT
When I'm in my sales role, I view every prospective client as falling into one of two broad baskets: those looking for a reason to say yes, and those looking for a reason to say no. I always try to focus on the former and spend little time on the...
IYK: 105.91 (+1.16), IYJ: 109.99 (+0.71), XTN: 111.14 (+0.79), IYH: 159.39 (+0.86), SWKS: 102.05 (+2.48), LSTR: 68.91 (+0.90), BBT: 39.81 (+0.25), IYM: 82.53 (+0.67), IYC: 147.34 (+1.37), XOM: 84.54 (+0.13), IYF: 91.39 (+1.22), IYE: 43.63 (+0.61), FMER: 19.42 (+0.31), IYZ: 31.26 (+0.37), SPY: 210.41 (+0.91), PSI: 28.21 (+0.45), IDU: 113.91 (+1.13), CAR: 58.88 (-0.05), CRUS: 33.72 (+0.34), IAT: 35.65 (+0.44), AAPL: 125.90 (-1.60), IYW: 107.91 (+0.62)

ETF flows: Out of financials, industrials, tech; into energy, healthcare
Seeking Alpha - at Seeking Alpha - Thu Mar 05, 1:08PM CST

UYG: 152.26 (+3.86), ROM: 161.96 (+2.30), QTEC: 44.99 (+0.46), FXL: 36.80 (+0.33), ERY: 20.70 (-0.95), RGI: 91.32 (+0.42), TECL: 150.33 (+2.54), ERX: 54.14 (+2.35), FXN: 20.99 (+0.27), FXO: 23.99 (+0.28), FNCL: 29.40 (+0.25), FAS: 130.56 (+4.47), FAZ: 11.64 (-0.46), FXH: 68.50 (+0.07), SEF: 17.19 (-0.22), VFH: 50.46 (+0.70), DDG: 26.19 (-0.47), REW: 50.64 (-0.80), UXI: 122.90 (+0.65), SIJ: 39.35 (unch), TECS: 9.91 (-0.16), FIDU: 29.35 (+0.13), FTEC: 32.82 (+0.06), FENY: 22.06 (+0.16), RWW: 49.89 (+0.52), RXD: 12.24 (-0.14), OIH: 33.30 (+0.74), RXL: 149.91 (+1.63), AIRR: 18.60 (+0.25), DUG: 54.08 (-1.44), PXJ: 15.98 (+0.23), VIS: 109.27 (+0.65), XLK: 42.54 (+0.10), FHLC: 36.29 (-0.04), XLI: 57.12 (+0.06), XLF: 24.71 (+0.24), RYE: 65.15 (+0.69), RYF: 45.57 (+0.43), CURE: 161.18 (+3.49), VHT: 139.38 (+0.70), XLE: 76.91 (+0.60), IYW: 107.91 (+0.62), FINZ: 20.88 (-1.18), RYH: 159.00 (+0.69), VDE: 108.48 (+1.29), IYJ: 109.99 (+0.71), IYH: 159.39 (+0.86), IGM: 106.03 (+0.92), DIG: 50.34 (+1.28), FINU: 89.26 (+3.59), IYG: 91.93 (+1.01), RYT: 94.16 (+0.66), IYF: 91.39 (+1.22), IYE: 43.63 (+0.61), XLV: 74.90 (+0.33), FXR: 31.61 (+0.24), MTK: 103.47 (+0.66), VGT: 108.77 (+0.62)

Stocks Break Out Again But May Be Running On Fumes
Scott Martindale - at Seeking Alpha - Tue Mar 03, 12:42AM CST
Despite low trading volume, a strong dollar, mixed economic and earnings reports, paralyzing weather conditions throughout much of the U.S., and ominous global news events, stocks continue to march ever higher. The world remains on edge about...
IYK: 105.91 (+1.16), IYJ: 109.99 (+0.71), VRX: 204.26 (+2.17), IYH: 159.39 (+0.86), IYM: 82.53 (+0.67), SLXP: 172.80 (+0.26), IYC: 147.34 (+1.37), ICE: 236.70 (-0.01), JBLU: 19.48 (+0.11), NXPI: 108.03 (+2.71), IYG: 91.93 (+1.01), BRCD: 12.37 (+0.16), IYF: 91.39 (+1.22), IYE: 43.63 (+0.61), IYZ: 31.26 (+0.37), SPY: 210.41 (+0.91), COMM: 30.86 (+0.25), AMG: 219.29 (+5.85), IDU: 113.91 (+1.13), IGN: 38.56 (+0.23), IYT: 164.35 (+0.32), FSL: 43.39 (+0.82), UNP: 117.45 (-0.10), IYW: 107.91 (+0.62)

Sector Rankings Stay Neutral With Few Bullish Catalysts On Horizon
Scott Martindale - at Seeking Alpha - Wed Feb 18, 12:49AM CST
Stocks are hitting new highs across the board, even though earnings reports have been somewhat disappointing. Actually, to be more precise, Q4 results have been pretty good, but it is forward guidance that has been cautious and/or cloudy as sales...
IYK: 105.91 (+1.16), ACHC: 72.77 (+1.17), IYJ: 109.99 (+0.71), BX: 38.69 (unch), IYH: 159.39 (+0.86), IYM: 82.53 (+0.67), IYC: 147.34 (+1.37), AMP: 136.17 (+2.83), IYF: 91.39 (+1.22), IYE: 43.63 (+0.61), KBWI: 69.39 (-0.26), IHF: 134.41 (+0.34), IYZ: 31.26 (+0.37), SPY: 210.41 (+0.91), MRVL: 15.72 (-0.08), IDU: 113.91 (+1.13), FONE: 40.83 (+0.46), MD: 72.46 (+0.32), AVGO: 133.29 (+1.25), IYW: 107.91 (+0.62)

Profiling Health Care ETFs - Why Medicine Is The Best Medicine
Aaron Barton - at Seeking Alpha - Thu Feb 12, 10:39AM CST

IYH: 159.39 (+0.86), PSCH: 68.93 (+0.03), FHLC: 36.29 (-0.04), IXJ: 110.64 (+1.24), VHT: 139.38 (+0.70), FXH: 68.50 (+0.07), XLV: 74.90 (+0.33)

Neutral Indicators And Mixed Reports, But Sector Rotation Model Is Bullish
Scott Martindale - at Seeking Alpha - Tue Feb 10, 12:20AM CST
Volatility continues as the parade of mixed earnings and economic reports marches along amidst a backdrop of global unrest and economic uncertainties. This has led to a neutral near-term outlook for both the technical picture and fundamentals-based...
IYK: 105.91 (+1.16), IYJ: 109.99 (+0.71), IYH: 159.39 (+0.86), IYM: 82.53 (+0.67), MCHP: 50.87 (+0.57), IYC: 147.34 (+1.37), AMP: 136.17 (+2.83), TDW: 20.59 (-0.68), TAN: 45.34 (+0.88), ALL: 71.46 (+0.86), IYF: 91.39 (+1.22), IYE: 43.63 (+0.61), KBWI: 69.39 (-0.26), IYZ: 31.26 (+0.37), FSLR: 60.26 (-0.04), SPY: 210.41 (+0.91), IDU: 113.91 (+1.13), XSD: 91.12 (+1.02), IYW: 107.91 (+0.62), CODE: 38.59 (+0.47)

Pfizer Set to Acquire Hospira: Healthcare ETFs in Focus - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Fri Feb 06, 9:00AM CST
Healthcare ETFs are worth a look given that Pfizer will buy Hospira.
IHE: 178.85 (-0.32), PPH: 71.99 (+0.73), IYH: 159.39 (+0.86), PFE: 34.25 (+0.10), HSP: 87.64 (-0.06), XLV: 74.90 (+0.33)

Volatility Continues As Earnings Reports Create Excitement And Despair
Scott Martindale - at Seeking Alpha - Mon Feb 02, 9:02PM CST
Volatility reigned in January on elevated volume as stock investors shifted their focus from global events to U.S. earnings reports, which have ranged from amazing (e.g., Apple) to crushing (e.g., Microsoft). Although the earnings reports have...
IYK: 105.91 (+1.16), BIIB: 475.98 (+42.33), CAVM: 73.81 (+1.33), IYJ: 109.99 (+0.71), KBWD: 25.67 (+0.28), IYH: 159.39 (+0.86), IYM: 82.53 (+0.67), IYC: 147.34 (+1.37), IBB: 366.52 (+1.27), SMH: 57.74 (+0.90), IT: 83.03 (+1.30), IYF: 91.39 (+1.22), IYE: 43.63 (+0.61), STWD: 24.51 (+0.35), IYZ: 31.26 (+0.37), SPY: 210.41 (+0.91), SUI: 71.27 (+2.30), IDU: 113.91 (+1.13), SHPG: 253.64 (+3.07), IYW: 107.91 (+0.62)

With The Fed Fading Into The Shadows, Investors Look Overseas For New Catalysts
Scott Martindale - at Seeking Alpha - Mon Jan 26, 1:50AM CST
Last week, the S&P 500 put an end to its streak of weekly losses, despite giving back some gains on Friday. Thursday provided the big catalyst, with the ECB's announcement of its bold new monetary stimulus plan. Investors were cheered and soothed...
AMBA: 72.39 (+3.14), IYK: 105.91 (+1.16), IYJ: 109.99 (+0.71), PCYC: 257.85 (-0.21), IYH: 159.39 (+0.86), SPG: 197.34 (+5.24), IYM: 82.53 (+0.67), INCY: 95.55 (-1.53), IYC: 147.34 (+1.37), IBB: 366.52 (+1.27), IYF: 91.39 (+1.22), IYE: 43.63 (+0.61), KBWI: 69.39 (-0.26), IYZ: 31.26 (+0.37), SPY: 210.41 (+0.91), PSI: 28.21 (+0.45), IDU: 113.91 (+1.13), PVTB: 35.86 (-0.09), IYW: 107.91 (+0.62), CODE: 38.59 (+0.47)

Healthcare ETFs in Focus on Mixed JNJ Results - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Wed Jan 21, 12:00PM CST
Healthcare ETFs are worth look following Johnson & Johnson mixed fourth quarter results.
JNJ: 102.40 (+0.71), IYH: 159.39 (+0.86), GILD: 102.29 (+0.85), VHT: 139.38 (+0.70), XLV: 74.90 (+0.33)

New Year Kicks Off With New Fears To Keep Investors On Edge
Scott Martindale - Seeking Alpha - Tue Jan 20, 4:47AM CST
As widely expected, the new year has begun with a lot of volatility on high trading volume, as investors fear more than just a mild correction to start out the year. Despite the strong fundamentals here in the U.S., there are plenty of dangers around...
IYK: 105.91 (+1.16), IYJ: 109.99 (+0.71), ACT: 317.06 (+2.65), IYH: 159.39 (+0.86), IYM: 82.53 (+0.67), UNH: 119.14 (-1.62), PSA: 199.12 (+4.88), IYC: 147.34 (+1.37), SMH: 57.74 (+0.90), NXPI: 108.03 (+2.71), IT: 83.03 (+1.30), IYF: 91.39 (+1.22), IYE: 43.63 (+0.61), LUV: 46.36 (+0.01), JLL: 169.56 (+5.10), PPH: 71.99 (+0.73), IYZ: 31.26 (+0.37), SPY: 210.41 (+0.91), IDU: 113.91 (+1.13), REM: 12.05 (+0.10), TYL: 125.29 (+1.82), IDXX: 152.80 (-1.65), IYW: 107.91 (+0.62)

Where Do Cures Reside? The Answer Is In Regenerative Medicine
Life Sciences Report - Seeking Alpha - Fri Jan 09, 7:37AM CST
The practice of medicine is being transformed. The journey has been arduous, but revolutionary stem cell, gene and immunocellular therapies are rapidly moving toward pivotal milestones-and investors in the space should strap in for a rewarding joy...
BBP: 32.37 (-0.23), RXL: 149.91 (+1.63), XBI: 233.86 (-4.12), IHE: 178.85 (-0.32), IHF: 134.41 (+0.34), PPH: 71.99 (+0.73), XHE: 95.03 (-0.32), BBC: 35.07 (-0.58), PTH: 63.31 (-0.61), BBH: 138.45 (+0.69), FHLC: 36.29 (-0.04), IHI: 120.98 (+0.18), CURE: 161.18 (+3.49), FXH: 68.50 (+0.07), VHT: 139.38 (+0.70), RYH: 159.00 (+0.69), PBE: 58.47 (-0.79), IYH: 159.39 (+0.86), FBT: 125.71 (-0.27), XHS: 125.51 (+0.62), XPH: 130.00 (-1.39), XLV: 74.90 (+0.33), SBIO: 31.04 (-0.89), PSCH: 68.93 (+0.03), PJP: 80.41 (+0.33), RXD: 12.24 (-0.14)

Kyle Bass's Assault On Pharma Patents
IP Hawk - at Seeking Alpha - Thu Jan 08, 12:25PM CST

BBP: 32.37 (-0.23), RXL: 149.91 (+1.63), XBI: 233.86 (-4.12), IBB: 366.52 (+1.27), IHE: 178.85 (-0.32), IHF: 134.41 (+0.34), BBC: 35.07 (-0.58), PPH: 71.99 (+0.73), XHE: 95.03 (-0.32), PTH: 63.31 (-0.61), BBH: 138.45 (+0.69), FHLC: 36.29 (-0.04), IHI: 120.98 (+0.18), CURE: 161.18 (+3.49), FXH: 68.50 (+0.07), VHT: 139.38 (+0.70), RYH: 159.00 (+0.69), PBE: 58.47 (-0.79), IYH: 159.39 (+0.86), FBT: 125.71 (-0.27), XHS: 125.51 (+0.62), XPH: 130.00 (-1.39), XLV: 74.90 (+0.33), SBIO: 31.04 (-0.89), PSCH: 68.93 (+0.03), PJP: 80.41 (+0.33), RXD: 12.24 (-0.14)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Capacitor Bank Market Growth Predictions Through 2033

Updated Category News Views 216

Capacitor Bank Market Set for Substantial Growth Recently, a comprehensive report highlighted the significant potential of the global capacitor bank market, forecasting a growth trajectory that sees its value increasing from $4.3 billion in 2023 to an impressive $6.8 billion by 2033. This translates to a compound annual growth rate (CAGR) of 4.8% during the period from...

Continue Reading
Understanding Rental Affordability Trends Across Major Markets

Updated Category News Views 291

Rental Affordability Trends in August 2024 As summer draws to a close, many renters are taking a close look at the housing market to gauge current affordability rates. A recent report highlights encouraging data, showing that rental affordability has generally improved in various major U.S. regions. This article outlines the key takeaways regarding rental affordability...

Continue Reading
Stallergenes Greer’s Palforzia® Gains European Approval for Toddlers

Updated Category News Views 134

Palforzia® Receives European Commission Approval for Toddlers Stallergenes Greer, a leader in allergen immunotherapy, has exciting news: the European Commission has officially approved the use of Palforzia® for toddlers aged 1 to 3 years with confirmed peanut allergies. This significant step enhances the treatment landscape for peanut allergies and opens new doors for...

Continue Reading
ProVen Growth and Income VCT's Latest Interim Management Insights

Updated Category News Views 174

ProVen Growth and Income VCT plc Overview ProVen Growth and Income VCT plc, known for its investment strategies and market presence, has released its Interim Management Statement for the recent quarter. This report highlights significant financial data and key developments that occurred from March to May 2025, offering shareholders insights into the company’s...

Continue Reading
Treefera Recognized as 2025 Gartner® Cool Vendor in Tech

Updated Category News Views 179

Treefera Honored as a 2025 Gartner® Cool Vendor Treefera has recently celebrated a significant milestone by being named a 2025 Gartner® Cool Vendor in Sourcing and Procurement Technology. This prestigious acknowledgment underscores Treefera's innovative contributions to the supply chain sector, particularly in providing first-mile visibility which is crucial for...

Continue Reading